Trial Profile
A retrospective study to evaluate the efficacy of Sofosbuvir based regimens in patients with hepatitis C virus infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 18 May 2016 New trial record
- 17 Apr 2016 Results (n=522) assessing the association between week 4 HCV RNA and SVR were presented at The International Liver Congress™ 2016.